8584 E. Washington Street #127
Chagrin Falls, OH 44023
United States
213 642 9268
https://www.novaccessglobal.com
Sektor(en): Healthcare
Branche: Biotechnology
Vollzeitmitarbeiter: 3
Name | Titel | Zahlen | Ausgeübt | Geburtsjahr |
---|---|---|---|---|
Dr. Dwain K. Morris-Irvin M.P.H., MPH, Ph.D. | CEO & Director | 155,43k | N/A | 1968 |
Mr. Neil J. Laird | Chief Financial Officer | N/A | N/A | 1953 |
Dr. Christopher Wheeler Ph.D. | President of Stemvax Therapeutics | N/A | N/A | N/A |
NovAccess Global Inc., a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. It specializes in cutting-edge research related to utilizing a patient's immune system to attack the cancer. The company was incorporated in 1997 and is headquartered in Chagrin Falls, Ohio.
NovAccess Global Inc.s ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.